{"product_id":"mapk3-antibody-sc-f1152","title":"ERK1 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eERK1 (MAPK3), an essential component of the mitogen-activated protein kinase (MAPK) family, plays a critical role in governing various cellular processes such as proliferation, differentiation, and survival. As a central element of the Ras\/Raf\/MEK\/ERK signaling pathway, ERK1 mediates cellular responses to external stimuli and plays regulates cancer cell growth. Depending on the literature source, MAPK3 may also be discussed as ERK1 and p44-MAPK.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm, nucleus, membrane, and cell junction, which can matter when signal is compared across treatments or changing cell states. Following MAPK3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eMAPK3 is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, nucleus, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm, nucleus, and membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MAPK3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MAPK3 reflect biology rather than handling. When interpreting MAPK3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep MAPK3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577630335321,"sku":"F1152-20UL","price":129.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577630368089,"sku":"F1152-100UL","price":289.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577630400857,"sku":"F1152-2X100UL","price":429.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1152-IHC1.jpg?v=1773599359","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/mapk3-antibody-sc-f1152","provider":"Absource Diagnostics","version":"1.0","type":"link"}